| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Neoplasm of the middle ear | 1.11e-05 | 12 | 20 | 3 | HP:0100799 | |
| HumanPheno | Cholesteatoma | 1.11e-05 | 12 | 20 | 3 | HP:0009797 | |
| Domain | ARM-type_fold | 4.22e-07 | 339 | 53 | 9 | IPR016024 | |
| Domain | Myosin_N | 8.10e-04 | 15 | 53 | 2 | IPR004009 | |
| Domain | Myosin_N | 8.10e-04 | 15 | 53 | 2 | PF02736 | |
| Domain | ARM-like | 9.91e-04 | 270 | 53 | 5 | IPR011989 | |
| Domain | Myosin_tail_1 | 1.17e-03 | 18 | 53 | 2 | PF01576 | |
| Domain | Myosin_tail | 1.17e-03 | 18 | 53 | 2 | IPR002928 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 1.31e-03 | 19 | 53 | 2 | IPR006553 | |
| Domain | Myosin-like_IQ_dom | 1.31e-03 | 19 | 53 | 2 | IPR027401 | |
| Domain | - | 1.31e-03 | 19 | 53 | 2 | 4.10.270.10 | |
| Domain | LRR_CC | 1.31e-03 | 19 | 53 | 2 | SM00367 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.94e-03 | 37 | 53 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.94e-03 | 37 | 53 | 2 | PF00122 | |
| Domain | MYOSIN_MOTOR | 5.20e-03 | 38 | 53 | 2 | PS51456 | |
| Domain | Myosin_head | 5.20e-03 | 38 | 53 | 2 | PF00063 | |
| Domain | Myosin_head_motor_dom | 5.20e-03 | 38 | 53 | 2 | IPR001609 | |
| Domain | MYSc | 5.20e-03 | 38 | 53 | 2 | SM00242 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 11150240 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 2.46e-06 | 2 | 55 | 2 | 11744674 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.46e-06 | 2 | 55 | 2 | 9382868 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 DYM ATP11B ARID5B HECTD4 ARHGEF38 KCNMA1 KDM2A RRBP1 MLPH LRCH3 PDZD2 | 2.88e-06 | 1489 | 55 | 12 | 28611215 |
| Pubmed | FOCAD TTYH1 PPP4R1 WAPL TXNDC15 COG1 APC2 ARID5B HECTD4 RRBP1 ANKRD6 | 4.51e-06 | 1285 | 55 | 11 | 35914814 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 7.36e-06 | 3 | 55 | 2 | 26059207 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 36515178 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 1985022 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 10388558 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.47e-05 | 4 | 55 | 2 | 11029314 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 11023856 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.47e-05 | 4 | 55 | 2 | 18417546 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12547197 | ||
| Pubmed | 1.95e-05 | 529 | 55 | 7 | 14621295 | ||
| Pubmed | Characterization of long cDNA clones from human adult spleen. | 1.97e-05 | 33 | 55 | 3 | 11214971 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 2.45e-05 | 5 | 55 | 2 | 30737693 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.45e-05 | 5 | 55 | 2 | 3829126 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 6196357 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.45e-05 | 5 | 55 | 2 | 12919077 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 20417199 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.67e-05 | 6 | 55 | 2 | 10077619 | |
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.67e-05 | 6 | 55 | 2 | 17559643 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.67e-05 | 6 | 55 | 2 | 10588881 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 5.13e-05 | 7 | 55 | 2 | 29758057 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 16819597 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 26993635 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 3864153 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 36200826 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 6.83e-05 | 8 | 55 | 2 | 14667415 | |
| Pubmed | The Effects of Genotype and Cell Environment on Melanoblast Differentiation in the House Mouse. | 8.78e-05 | 9 | 55 | 2 | 17247639 | |
| Pubmed | Discovery of tissue-specific exons using comprehensive human exon microarrays. | 8.78e-05 | 9 | 55 | 2 | 17456239 | |
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 31960486 | ||
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 19506036 | ||
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 18310078 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.34e-04 | 11 | 55 | 2 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.34e-04 | 11 | 55 | 2 | 29168801 | |
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.34e-04 | 11 | 55 | 2 | 16024798 | |
| Pubmed | 1.89e-04 | 13 | 55 | 2 | 24876128 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.89e-04 | 13 | 55 | 2 | 8404542 | |
| Pubmed | 2.21e-04 | 14 | 55 | 2 | 24938781 | ||
| Pubmed | 2.21e-04 | 14 | 55 | 2 | 27184118 | ||
| Pubmed | 2.21e-04 | 14 | 55 | 2 | 33742095 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 2.54e-04 | 15 | 55 | 2 | 24852826 | |
| Pubmed | Interaction of the murine dilute suppressor gene (dsu) with fourteen coat color mutations. | 2.54e-04 | 15 | 55 | 2 | 2379821 | |
| Pubmed | Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. | 2.54e-04 | 15 | 55 | 2 | 18715234 | |
| Pubmed | 2.54e-04 | 15 | 55 | 2 | 6696991 | ||
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 16494860 | ||
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 5424503 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.90e-04 | 16 | 55 | 2 | 19922871 | |
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 3.29e-04 | 17 | 55 | 2 | 22351927 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 3.70e-04 | 18 | 55 | 2 | 25753484 | |
| Pubmed | 4.49e-04 | 225 | 55 | 4 | 12168954 | ||
| Pubmed | 4.58e-04 | 20 | 55 | 2 | 26341476 | ||
| Pubmed | 5.56e-04 | 22 | 55 | 2 | 24301466 | ||
| Pubmed | 5.75e-04 | 102 | 55 | 3 | 10231032 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.55e-04 | 440 | 55 | 5 | 34244565 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 7.79e-04 | 26 | 55 | 2 | 15890332 | |
| Pubmed | 7.79e-04 | 26 | 55 | 2 | 26586428 | ||
| Pubmed | 7.79e-04 | 26 | 55 | 2 | 11551941 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.06e-03 | 736 | 55 | 6 | 29676528 | |
| Pubmed | 1.11e-03 | 31 | 55 | 2 | 30081710 | ||
| Pubmed | 1.11e-03 | 31 | 55 | 2 | 21985497 | ||
| Pubmed | 1.18e-03 | 32 | 55 | 2 | 24954895 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.26e-03 | 33 | 55 | 2 | 32094117 | |
| Pubmed | 1.26e-03 | 33 | 55 | 2 | 24204828 | ||
| Pubmed | 1.32e-03 | 515 | 55 | 5 | 31617661 | ||
| Pubmed | 1.54e-03 | 1084 | 55 | 7 | 11544199 | ||
| Cytoband | 11q13.2 | 1.47e-03 | 47 | 55 | 2 | 11q13.2 | |
| GeneFamily | Myosin heavy chains | 3.34e-04 | 15 | 33 | 2 | 1098 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.20e-07 | 188 | 55 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 182 | 55 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.93e-06 | 192 | 55 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.03e-06 | 193 | 55 | 5 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.68e-06 | 199 | 55 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Mesoderm|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.53e-05 | 39 | 55 | 3 | 3479d255b87fa8042c51d80a3eb81a774850132e | |
| ToppCell | TCGA-Uvea|World / Sample_Type by Project: Shred V9 | 2.78e-05 | 141 | 55 | 4 | 015451a83087f2705d3315ebc8f23797c6f10ed6 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 162 | 55 | 4 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 162 | 55 | 4 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 166 | 55 | 4 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.51e-05 | 168 | 55 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.21e-05 | 62 | 55 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.21e-05 | 62 | 55 | 3 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 175 | 55 | 4 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-05 | 175 | 55 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-05 | 175 | 55 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.05e-05 | 179 | 55 | 4 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.05e-05 | 179 | 55 | 4 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.21e-05 | 180 | 55 | 4 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-05 | 181 | 55 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 7.85e-05 | 184 | 55 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.85e-05 | 184 | 55 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-05 | 184 | 55 | 4 | 9f8cd5ab5af6c35a1be25d70a125b9a3f4dd667a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.01e-05 | 185 | 55 | 4 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.01e-05 | 185 | 55 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.18e-05 | 186 | 55 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 8.18e-05 | 186 | 55 | 4 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.35e-05 | 187 | 55 | 4 | ab6f4d387218b4651fdadbf269806c1ddc96a1d2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 187 | 55 | 4 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 187 | 55 | 4 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.35e-05 | 187 | 55 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-05 | 188 | 55 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.52e-05 | 188 | 55 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.52e-05 | 188 | 55 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.70e-05 | 189 | 55 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.88e-05 | 190 | 55 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.88e-05 | 190 | 55 | 4 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.88e-05 | 190 | 55 | 4 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.88e-05 | 190 | 55 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 9.06e-05 | 191 | 55 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.06e-05 | 191 | 55 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-05 | 191 | 55 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-05 | 191 | 55 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 9.06e-05 | 191 | 55 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 18-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 9.25e-05 | 192 | 55 | 4 | 9fae988ecd2ef1231bfd42a678a4903517694cbe | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.25e-05 | 192 | 55 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.25e-05 | 192 | 55 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 9.25e-05 | 192 | 55 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 9.43e-05 | 193 | 55 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 9.43e-05 | 193 | 55 | 4 | f0a07bb221a497a9f7cc706045d5205269be4515 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.62e-05 | 194 | 55 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 18-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 9.62e-05 | 194 | 55 | 4 | 9a2efa50731135a178141aae55fa8b3e022c9904 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.62e-05 | 194 | 55 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.82e-05 | 195 | 55 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-05 | 195 | 55 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-04 | 196 | 55 | 4 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.06e-04 | 199 | 55 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 199 | 55 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| Disease | lean body mass | 5.95e-05 | 379 | 53 | 6 | EFO_0004995 | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 8.80e-05 | 8 | 53 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.41e-04 | 10 | 53 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.07e-04 | 12 | 53 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.07e-04 | 12 | 53 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.44e-04 | 13 | 53 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.27e-04 | 15 | 53 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myocardial infarction | 4.11e-04 | 350 | 53 | 5 | EFO_0000612 | |
| Disease | Meckel syndrome type 1 | 4.75e-04 | 18 | 53 | 2 | C3714506 | |
| Disease | diet measurement, fasting blood insulin measurement | 7.15e-04 | 22 | 53 | 2 | EFO_0004466, EFO_0008111 | |
| Disease | diet measurement, HOMA-IR | 7.82e-04 | 23 | 53 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 1.00e-03 | 26 | 53 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.21e-03 | 445 | 53 | 5 | EFO_0004314, GO_0097366 | |
| Disease | Intellectual Disability | 1.23e-03 | 447 | 53 | 5 | C3714756 | |
| Disease | coronary artery disease | 1.23e-03 | 1194 | 53 | 8 | EFO_0001645 | |
| Disease | Age related macular degeneration | 1.33e-03 | 30 | 53 | 2 | C0242383 | |
| Disease | Global developmental delay | 1.78e-03 | 133 | 53 | 3 | C0557874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLSSALLHANHTLST | 121 | Q9H313 | |
| LSDLSINSTECLHVH | 171 | P05156 | |
| TSLSLSHDQLHLLSC | 506 | Q8NAA4 | |
| SHDQLHLLSCSRDNT | 511 | Q8NAA4 | |
| HQILSQTSHDLNECS | 496 | Q14511 | |
| LSNALNSCHDFASHL | 401 | Q9NXL2 | |
| CLVSQHLQALSSTAS | 741 | A5YM72 | |
| SASCSHQLLAQAATL | 1046 | Q96MI9 | |
| HLACQNSHSQSTRVL | 146 | Q9Y2G4 | |
| ENSHTLLSHNACNKL | 426 | Q5VWP3 | |
| TLDLHSSLHQTCAEN | 496 | Q6ZS30 | |
| LLSLSASHNQLSHTD | 451 | Q96II8 | |
| CNSSLTLKTHHVQDS | 381 | P41594 | |
| SSNIHANHLSLDASS | 26 | Q12791 | |
| CELASALSHLDASHL | 1196 | O15018 | |
| NNHLLALDHSNSDLS | 201 | Q8IXT1 | |
| SALAHALQSSRHDCD | 1331 | P12882 | |
| SSILLAQSLQHCIHS | 2501 | Q9Y4D8 | |
| NCRNSHSLTTEHNLS | 111 | Q9H0J9 | |
| CLQTLLQHLTSHSLT | 626 | O95996 | |
| LSRLDLSHCSHLTDQ | 1066 | Q9Y2K7 | |
| LSHCSHLTDQSSNLL | 1071 | Q9Y2K7 | |
| CHLHSLLQLDSSSSR | 151 | Q8WTW3 | |
| LEIINSCLTNSLHHN | 536 | Q7RTS9 | |
| SSLCSLNSSLHEGHS | 251 | P28221 | |
| AAATSLHDLHCNTTI | 121 | Q969L2 | |
| EATSCSLHRSAHNAT | 61 | Q9HBE5 | |
| HSNCHSAISLLTNDR | 141 | Q6UWX4 | |
| SHATALATLRQCSHE | 211 | Q9C0E4 | |
| LHCSAAAHSSEQSLV | 41 | Q9BQ95 | |
| HLHLSTLSSSQSRAS | 1336 | Q5VW36 | |
| ELLSDTAHLNETHCA | 51 | Q9BV36 | |
| LSSLLDLHASQTCSL | 1021 | A6NES4 | |
| HVLSSNESSLRSSNH | 186 | Q86VV8 | |
| LLCTLSSESHQEAAS | 406 | Q8TF05 | |
| CLNNSDHDRLHTLVT | 151 | Q9BRJ2 | |
| DTNHSLCLSDLSLLS | 331 | Q14872 | |
| STLAHALQSARHDCD | 1331 | Q9Y623 | |
| DDLCSSLSQTHHGQS | 726 | Q14865 | |
| HRSVLSLNLNCSSHR | 286 | Q96M02 | |
| LSHLNNLSHLTTSSS | 456 | Q9Y2G3 | |
| LLHCVSRSHSQNATA | 26 | Q9BX73 | |
| LCHTQSSHASLRADA | 891 | Q9P2E9 | |
| LQHHADLTCTTTLDL | 436 | O75030 | |
| LTCLTAQTHSLLQHQ | 211 | Q7Z7H8 | |
| SDHLCNIALQESHSA | 606 | Q12767 | |
| HFLALDASQHSSLST | 241 | Q96J42 | |
| SHDILQHQDSNCSAT | 21 | Q9BZA5 | |
| TLDDSQHHQNLSLCT | 706 | Q7Z5K2 | |
| HAILNLCHETDLHSS | 741 | Q5SRE5 | |
| SCSSLAATLLANHSL | 386 | P13489 | |
| HQSEALALASSQSHL | 876 | Q8NB14 | |
| LKSTDCSNATHSLLH | 161 | Q9H0C1 | |
| HCDSKLQSTAELTSH | 1896 | Q96JM2 | |
| HISSAALSLNSLHTV | 351 | Q9NX45 | |
| SASHNSSCSAHLLIQ | 126 | Q96GX1 | |
| QRLCHSESHNDSVLA | 16 | Q96NJ5 |